We have become much more responsive to the needs of our strategic partners and it has proven to be an effective strategy. We will use these funds to accelerate our clinical development programs, build our Chromax chromium picolinate brand, and to expand our patent enforcement efforts. Our patent enforcement efforts are strengthening the significant competitive advantages enjoyed by Nutrition 21 and our customers. Nutrition 21, Inc. develops and markets clinically substantiated products that make a significant contribution to the health and well being of consumers. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission.
Actual results can differ materially.
The company makes no commitment to disclose any revisions to forward-looking statements.